BOONTON, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE), a world leader in the design, delivery, manufacture and development of peptide-based therapeutics, today announced it will present at the Rodman & Renshaw 12th Annual Healthcare Conference at 2:50 p.m. Eastern Time on September 14, 2010, in New York, NY. Unigene’s President and Chief Executive Officer Ashleigh Palmer will present on the Company’s new corporate strategy and business development initiatives to enhance Unigene’s presence in the rapidly growing peptide space. A key component of this strategy is Unigene’s Peptelligence™ platform, representing a distinctive competence originating from the Company’s proprietary expertise and validated suite of patented peptide drug delivery and manufacturing technologies.
